Modification of an Injectable Chitosan Scaffold by Blending with NaHCO 3 to Improve Cytocompatibility
Source abstract
Abstract
The chitosan/β-glycerophosphate (C/GP) system, which allows injection at room temperature and gel-formation at body temperature, can be considered as a candidate for injectable scaffolds. To improve the cytocompatiblity of the C/GPhydrogel, we used NaHCO 3 as buffer to neutralize chitosan solution and lower the GP concentration from 400 to 135 mM. The chitosan/β-glycerophosphate//NaHCO 3 (C/GP/NaHCO 3 ) system was liquid before injection and became a three-dimensional porous hydrogel at body temperature, as revealed by scanning electron microscopy (SEM). The C/GP/NaHCO 3 hydrogels showed higher cytocompatibility with rat bone marrow-derived mesenchymal stem cells (rBMSCs) in vitro compared to C/GP hydrogels. Our results indicated that the C/GP/NaHCO 3 system was suitable as an injectable scaffold for tissue engineering.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Hydrogels: synthesis, properties, applications · Electrospun Nanofibers in Biomedical Applications · Tissue Engineering and Regenerative Medicine
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Key Laboratory of Advanced Materials, Department of Materials Science and Engineering, Tsinghua University, Beijing 100084, China
Department of Orthopaedics, Zhujiang Hospital of Southern Medical University, Guangzhou 510282, China
References (33)
Show source-provided references
1. 10.1002/adma.20080200910.1002/adma.200802009 ↗
2. 10.1089/ten.tea.2008.070410.1089/ten.tea.2008.0704 ↗
3. 10.1016/S0142-9612(03)00026-710.1016/S0142-9612(03)00026-7 ↗
4. 10.1002/jbm.b.3042510.1002/jbm.b.30425 ↗
5. 10.1177/02624893090280030110.1177/026248930902800301 ↗
6. 10.1016/S0142-9612(00)00116-210.1016/S0142-9612(00)00116-2 ↗
7. 10.1002/jbm.b.3131110.1002/jbm.b.31311 ↗
8. 10.1007/s10856-006-9226-610.1007/s10856-006-9226-6 ↗
9. 10.1016/j.joca.2006.06.01510.1016/j.joca.2006.06.015 ↗
10. 10.1088/1748-6041/4/5/05500510.1088/1748-6041/4/5/055005 ↗
11. 10.1089/ten.tea.2007.030510.1089/ten.tea.2007.0305 ↗
12. 10.1002/jbm.a.3136510.1002/jbm.a.31365 ↗
13. 10.1016/j.biomaterials.2007.09.01810.1016/j.biomaterials.2007.09.018 ↗
14. 10.1016/j.joca.2004.12.00110.1016/j.joca.2004.12.001 ↗
15. 10.1039/b401791a10.1039/b401791a ↗
16. 10.1016/S0142-9612(02)00004-210.1016/S0142-9612(02)00004-2 ↗
17. 10.1002/app.2972110.1002/app.29721 ↗
18. 10.1016/j.carbpol.2008.11.02010.1016/j.carbpol.2008.11.020 ↗
19. 10.1177/088391150404264310.1177/0883911504042643 ↗
20. 10.1016/S0142-9612(00)00220-910.1016/S0142-9612(00)00220-9 ↗
21. 10.1016/j.carbpol.2007.09.01810.1016/j.carbpol.2007.09.018 ↗
22. 10.1016/S0142-9612(99)00192-110.1016/S0142-9612(99)00192-1 ↗
23. Lynch M.P. · Experimental Cell Research · 1995 · 216 · 3510.1006/excr.1995.1005 ↗
24. 10.1177/088532820810053610.1177/0885328208100536 ↗
25. 10.1016/S0144-8617(00)00281-210.1016/S0144-8617(00)00281-2 ↗
26. 10.1021/bm050313s10.1021/bm050313s ↗
27. 10.1007/s10971-006-9007-110.1007/s10971-006-9007-1 ↗
28. 10.1016/S8756-3282(98)00139-210.1016/S8756-3282(98)00139-2 ↗
29. 10.1016/0169-6009(91)90101-510.1016/0169-6009(91)90101-5 ↗
30. 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I ↗
31. 10.1016/j.biomaterials.2005.11.01310.1016/j.biomaterials.2005.11.013 ↗
32. 10.1016/j.biomaterials.2008.04.03910.1016/j.biomaterials.2008.04.039 ↗
33. 10.1016/j.msec.2005.06.06210.1016/j.msec.2005.06.062 ↗